HomeCompareNHPHF vs ORCC

NHPHF vs ORCC: Dividend Comparison 2026

NHPHF yields 11235.96% · ORCC yields 9.79%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 NHPHF wins by $174014503058918784.00M in total portfolio value
10 years
NHPHF
NHPHF
● Live price
11235.96%
Share price
$0.02
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$174014503058918784.00M
Annual income
$171,020,339,314,715,920,000,000.00
Full NHPHF calculator →
ORCC
ORCC
● Live price
9.79%
Share price
$13.48
Annual div
$1.32
5Y div CAGR
-50%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$21.4K
Annual income
$1.04
Full ORCC calculator →

Portfolio growth — NHPHF vs ORCC

📍 NHPHF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodNHPHFORCC
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, NHPHF + ORCC cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
NHPHF pays
ORCC pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

NHPHF
Annual income on $10K today (after 15% tax)
$955,056.18/yr
After 10yr DRIP, annual income (after tax)
$145,367,288,417,508,530,000,000.00/yr
ORCC
Annual income on $10K today (after 15% tax)
$832.34/yr
After 10yr DRIP, annual income (after tax)
$0.88/yr
At 15% tax rate, NHPHF beats the other by $145,367,288,417,508,530,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of NHPHF + ORCC for your $10,000?

NHPHF: 50%ORCC: 50%
100% ORCC50/50100% NHPHF
Portfolio after 10yr
$87007251529459392.00M
Annual income
$85,510,169,657,357,960,000,000.00/yr
Blended yield
98.28%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on ORCC right now

NHPHF
No analyst data
ORCC
Analyst Ratings
9
Buy
4
Hold
1
Sell
Consensus: Buy
Price Target
$16.00
+18.7% upside vs current
Range: $16.00 — $16.00
Altman Z
0.5
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

NHPHF buys
0
ORCC buys
0
No recent congressional trades found for NHPHF or ORCC in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricNHPHFORCC
Forward yield11235.96%9.79%
Annual dividend / share$2.00$1.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%-50%
Portfolio after 10y$174014503058918784.00M$21.4K
Annual income after 10y$171,020,339,314,715,920,000,000.00$1.04
Total dividends collected$173815634005153056.00M$1.0K
Payment frequencyquarterlyquarterly
SectorStockBDC

Year-by-year: NHPHF vs ORCC ($10,000, DRIP)

YearNHPHF PortfolioNHPHF Income/yrORCC PortfolioORCC Income/yrGap
1← crossover$1,134,296$1,123,595.51$11,190$489.61+$1.12MNHPHF
2$120,324,849$119,111,152.54$12,229$256.01+$120.31MNHPHF
3$11,937,329,931$11,808,582,343.08$13,216$130.74+$11937.32MNHPHF
4$1,107,651,266,465$1,094,878,323,438.19$14,207$66.02+$1107651.25MNHPHF
5$96,131,461,889,299$94,946,275,034,181.42$15,234$33.17+$96131461.87MNHPHF
6$7,804,029,623,842,993$7,701,168,959,621,443.00$16,317$16.62+$7804029623.83MNHPHF
7$592,637,329,032,509,800$584,287,017,334,997,900.00$17,468$8.32+$592637329032.49MNHPHF
8$42,102,070,670,847,810,000$41,467,948,728,783,030,000.00$18,695$4.16+$42102070670847.80MNHPHF
9$2,798,283,873,086,806,700,000$2,753,234,657,468,999,500,000.00$20,006$2.08+$2798283873086806.50MNHPHF
10$174,014,503,058,918,800,000,000$171,020,339,314,715,920,000,000.00$21,407$1.04+$174014503058918784.00MNHPHF

NHPHF vs ORCC: Complete Analysis 2026

NHPHFStock

Lumiera Health Inc., together with its subsidiaries, develops and commercializes evidence-based botanical products for the healthcare in Canada. It sells oral and topical botanical agents to manage unmet medical needs; and solutions for sleep-aids and pain management. The company offers herbal tonics and supplements for cardiovascular health, stress relief, bones, joints and muscle mobility, and energy and immunity under the Holizen brand; sleep aid products under the Bazzzics brand; and pain relief cream under the Awaye brand. Lumiera Health Inc. is headquartered in Saint-Hubert, Canada.

Full NHPHF Calculator →

ORCCBDC

Owl Rock Capital Corporation is a business development company. The fund makes investments in senior secured or unsecured loans, subordinated loans or mezzanine loans and also considers equity-related securities including warrants and preferred stocks also pursues preferred equity investments and common equity investments. Within private equity, it seeks to invest in growth, acquisitions, market or product expansion, refinancings and recapitalizations. It seeks to invest in middle market companies based in the United States, with EBITDA between $10 million and $250 million annually and/or annual revenue of $50 million and $2.5 billion at the time of investment.

Full ORCC Calculator →
📬

Get this NHPHF vs ORCC comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

NHPHF vs SCHDNHPHF vs JEPINHPHF vs ONHPHF vs KONHPHF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.